Hix Christopher M's Form 4 filing
ESAB Corp (ESAB) · filed Feb 22, 2023
- Accession no.
- 0001209191-23-011830
- Filed
- Feb 22, 2023
- Trade date
- Feb 17-21, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $93.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hix Christopher MCIK 0001357529 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common stock, par value $0.001 | MOption exerciseAcquired | +3,217 | –F1 | – | 37,417 | Direct | |
| Feb 21, 2023 | Common stock, par value $0.001 | SSaleDisposed | −1,609 | $57.82 | −$93,032.38 | 35,808 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | Common stock, par value $0.001 | MOption exerciseDisposed | −3,217 | $0.00 | $0 | 6,432 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
Referenced by the price of 1 transaction in Table I.